Sources

[←1]

^{Frankel, J. P., et al. “Marijuana for parkinsonian tremor.” Journal of neurology, neurosurgery, and psychiatry 53.5 (1990): 436.}

[←2]

^{Venderová, Kateřina, et al. “Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms.” Movement Disorders 19.9 (2004): 1102-1106.}

[←3]

^{Lotan, Itay, et al. “Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study.” Clinical neuropharmacology 37.2 (2014): 41-44.}

[←4]

^{Finseth, Taylor Andrew, et al. “Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado.” Evidence-Based Complementary and Alternative Medicine 2015 (2015).}

[←5]

^{Zuardi, A. W., et al. “Cannabidiol for the treatment of psychosis in Parkinson’s disease.” Journal of Psychopharmacology (2008).}

[←6]

^{Fernández‐Ruiz, Javier. “The endocannabinoid system as a target for the treatment of motor dysfunction.” British journal of pharmacology 156.7 (2009): 1029-1040.}

[←7]

^{Lastres-Becker, Isabel, et al. “Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.” Neurobiology of disease 19.1 (2005): 96-107.}

[←8]

^{Fernández‐Ruiz, Javier, et al. “Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?.” British journal of clinical pharmacology 75.2 (2013): 323-333.}